Glaxo Wellcome's two new drugs.
D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002219:Carbamates; D015224:Dideoxynucleosides / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005663:Furans; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use*; D000099227:Abacavir
D019380:Anti-HIV Agents; D002219:Carbamates; D015224:Dideoxynucleosides; D005663:Furans; D017320:HIV Protease Inhibitors; D013449:Sulfonamides; D000099227:Abacavir; C095108:amprenavir